Laurence Skillern
Author
Alternate names L. Skillern, L. H. Skillern, Laurence Skillern
Institution Astellas Pharma (United Kingdom)
Past institutions Astellas Pharma (United Kingdom), Astellas Pharma (Netherlands), Pfizer (United Kingdom), Pfizer (United States), University of Manchester +5 more
H-index: 10
I10-index: 11
Works count: 23
Citations count: 534
A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of Preeclampsia
2009 · Rebekah A. Samangaya, Gary Mires, et al. · Hypertension in Pregnancy
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause
2020 · Graeme L. Fraser, Samuel Lederman, et al. · Menopause The Journal of The North American Menopause Society
Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries
2004 · Mark Wareing, Jenny Myers, et al. · American Journal of Obstetrics and Gynecology